Dynavax Technologies Competitors and Similar CompaniesClear all

Dynavax Technologies's competitors and similar companies include YiChang HEC ChangJiang Pharmaceutical and UCB.

	Dynavax Technologies Dynavax Technologies Corporation is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious, autoimmune and inflammatory diseases, and the treatment of cancer.	YiChang HEC ChangJiang Pharmaceutical YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date	Founding Date 1996	Founding Date 2001	Founding Date 1928
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Emeryville, US HQ Düsseldorf, DE Berkeley, US	Locations HQ	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more
Employees	Employees 24946% increase	Employees 4,595	Employees 9,052
Valuation ($)	Valuation ($) 1.5 b	Valuation ($) N/A	Valuation ($) 34.3 b
Financial
Revenue (est.)	Revenue (est.) $277.2m (FY, 2024)	Revenue (est.) ¥3.7b (FY, 2024)	Revenue (est.) €7.4b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods ¥533.6m (FY, 2024)	Cost of goods €1.4b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit ¥3.2b (FY, 2024)	Gross profit €7.2b (FY, 2025)
Net income	Net income $27.3m (FY, 2024)	Net income ¥482.7m (FY, 2024)	Net income €1.6b (FY, 2025)